ChemoAlert is a specialized surface sampling kit designed for hospitals, pharmacies, infusion centers, and other facilities that handle chemotherapy drugs. It helps detect potential drug residue on workplace surfaces to protect healthcare workers from unintended exposure to antineoplastic drugs. Developed in compliance with USP <800> and NAPRA regulations, ChemoAlert supports a regular testing regimen—recommended every six months in North America—to ensure a safe working environment.
Key features of the ChemoAlert kit include:
- Comprehensive Sampling Tools: Contains swabs, vials, templates, wetting agent, gloves, and an ice pack to maintain sample integrity during shipping and storage.
- Regulatory Compliance: Engineered to meet USP <800> and NAPRA requirements for the safe handling of hazardous drugs.
- Fast and Reliable Analysis: After sample collection, swabs are shipped to an AIHA LAP, LLC accredited laboratory with results typically available within 10 business days; same-day rush results can be requested.
- Versatile Sampling Areas: Suitable for testing benches, compounding areas, ante chambers, hoods, phones, balances, patient furniture, floors, bathrooms, cafeterias, and door handles.
By providing a complete, easy-to-use kit for collecting and analyzing hazardous drug residues, ChemoAlert offers peace of mind and plays a critical role in maintaining workplace safety across healthcare settings.
